Avalon Quantum AI Announces Strategic AWS Collaboration for Agentic AI Video Platform
Avalon Quantum AI Announces Strategic AWS Collaboration for Agentic AI Video Platform
Key Points for Investors
- Avalon Quantum AI LLC, a subsidiary of Avalon GloboCare Corp. (NASDAQ: ALBT), partners with Amazon Web Services (AWS) and Caylent for the next phase of its Catch-Up agentic AI video platform development.
- Development is expected to transform Catch-Up from a manually-configured tool into a fully autonomous, agentic AI video system for content creators.
- Caylent, an AWS Premier Tier Consulting Partner with multiple AWS awards, will lead the technical development.
- The collaboration is seen as a validation of Avalon’s technology and growth strategy, and is expected to accelerate product rollouts and market reach.
Detailed Article
FREEHOLD, N.J., April 21, 2026 – Avalon GloboCare Corp. (“Avalon,” NASDAQ: ALBT), a technology-innovation company focused on the consumer health and technology markets, announced a significant step forward in the development of its agentic AI video platform, “Catch-Up.” Avalon’s wholly-owned subsidiary, Avalon Quantum AI LLC, will collaborate with Amazon Web Services (AWS) and Caylent, Inc. for the Phase 2 development of this platform.
Strategic Collaboration with AWS and Caylent
The partnership with AWS, one of the world’s largest and most trusted cloud computing providers, and Caylent, an AWS Premier Tier Consulting Partner, represents a major endorsement of Avalon’s AI technology and market strategy. Caylent brings deep expertise in AWS cloud solutions, generative AI, and application modernization, and has been recognized with several AWS awards, including GenAI Industry Solution Partner of the Year, Industry Partner of the Year – Financial Services (2024), Application Modernization Partner of the Year (2023), Innovation Partner of the Year (2022), and Rising Star Partner of the Year (2021).
Caylent will lead the technical development of the Catch-Up platform’s second phase, which aims to transform the current system—now manually configured—into a fully autonomous, agentic AI video platform. The new platform is intended to enable content creators, especially those without significant technical expertise, to easily generate high-quality, personalized video content for multiple social media channels.
Implications for Shareholders and Potential Share Price Impact
-
Market Validation & Accelerated Development: The involvement of AWS and Caylent not only validates Avalon’s technological approach but is also expected to expedite the commercialization of its Catch-Up platform. This could lead to faster adoption and broader market penetration, which may positively impact revenue growth and, by extension, the company’s valuation.
-
Scalability & Monetization: According to Avalon’s Interim CEO and COO, Meng Li, the partnership is expected to strengthen the company’s ability to scale efficiently and drive long-term monetization. The anticipated transition to a fully autonomous AI platform could open new markets, particularly among small businesses and content creators looking for advanced video solutions without technical barriers.
-
Expansion of Product Portfolio: Beyond Catch-Up, Avalon is also active in other consumer health technology markets, including the KetoAir™ breathalyzer, a non-invasive device for measuring ketosis levels registered as a Class I medical device with the FDA and sold in North America. This diversification could help mitigate risks and support growth.
Forward-Looking Statements
Investors should be aware that the statements regarding the development and commercialization of the Catch-Up platform, its market potential, and the impact of the AWS collaboration are forward-looking and subject to risks and uncertainties. Factors such as technology adoption rates, competitive pressures, regulatory changes, and broader economic conditions could materially affect outcomes. As always, investors should consult the company’s filings with the SEC for a comprehensive assessment of risks.
Contact and Further Information
Disclaimer: This article contains forward-looking statements that are subject to risks and uncertainties. Actual results may differ materially from those projected due to various factors, including but not limited to market conditions, regulatory changes, and technological developments. Investors should review the company’s filings with the SEC and consult a financial advisor before making investment decisions. This article is for informational purposes only and does not constitute investment advice.
View Avalon GloboCare Corp. Historical chart here
